759 related articles for article (PubMed ID: 18437601)
1. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
2. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
3. NK cell-based cancer immunotherapy.
Stagg J; Smyth MJ
Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
[TBL] [Abstract][Full Text] [Related]
4. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
Wesa AK; Storkus WJ
Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
6. NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
Fuller CL; Ruthel G; Warfield KL; Swenson DL; Bosio CM; Aman MJ; Bavari S
Cell Microbiol; 2007 Apr; 9(4):962-76. PubMed ID: 17381429
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
[TBL] [Abstract][Full Text] [Related]
8. Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production.
Terrazzano G; Pisanti S; Grimaldi S; Sica M; Fontana S; Carbone E; Zappacosta S; Ruggiero G
Scand J Immunol; 2004 Apr; 59(4):356-62. PubMed ID: 15049779
[TBL] [Abstract][Full Text] [Related]
9. Killer dendritic cells and their potential role in immunotherapy.
Ullrich E; Chaput N; Zitvogel L
Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
Terme M; Ullrich E; Delahaye NF; Chaput N; Zitvogel L
Nat Immunol; 2008 May; 9(5):486-94. PubMed ID: 18425105
[TBL] [Abstract][Full Text] [Related]
12. Functions of natural killer cells.
Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
14. Resistance against natural killer cell cytotoxicity: analysis of mechanisms.
Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B
Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
[TBL] [Abstract][Full Text] [Related]
16. NK cell receptors as tools in cancer immunotherapy.
Sentman CL; Barber MA; Barber A; Zhang T
Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
[TBL] [Abstract][Full Text] [Related]
17. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.
Iannello A; Debbeche O; Samarani S; Ahmad A
J Leukoc Biol; 2008 Jul; 84(1):27-49. PubMed ID: 18388299
[TBL] [Abstract][Full Text] [Related]
18. Viral modulation of NK cell immunity.
Lodoen MB; Lanier LL
Nat Rev Microbiol; 2005 Jan; 3(1):59-69. PubMed ID: 15608700
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
Sutlu T; Alici E
J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
[TBL] [Abstract][Full Text] [Related]
20. Helper role of NK cells during the induction of anticancer responses by dendritic cells.
Kalinski P; Giermasz A; Nakamura Y; Basse P; Storkus WJ; Kirkwood JM; Mailliard RB
Mol Immunol; 2005 Feb; 42(4):535-9. PubMed ID: 15607810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
